Novo Nordisk
GLP-1s Opened the Door, Hims & Hers Says Personalization Holds the Key
Hims & Hers' Dr. Craig Primack explains why personalized care, not just GLP-1s, is the key to lasting weight loss success.
Post-Hims & Hers Breakup, Novo Nordisk Strengthens WeightWatchers Ties
With a pharma giant in its corner, WeightWatchers is mounting a comeback, relying on FDA-approved GLP-1 medications.
Wegovy Partnership Unravels as Novo Nordisk, Hims & Hers Trade Accusations
Novo Nordisk ends its Wegovy deal with Hims & Hers, citing safety concerns as the telehealth firm pushes back.
Hims & Hers Joins Forces With Novo Nordisk
Hims & Hers and Novo Nordisk are teaming to expand affordable access to weight loss treatments, launching a bundled Wegovy offering.
